✦ LIBER ✦

A pilot study of irinotecan (CPT-11) as single-agent therapy in patients with locally advanced or metastatic esophageal carcinoma

✍ Scribed by F. Mühr-Wilkenshoff,W. Hinkelbein…

Book ID: 113036889
Publisher: Springer
Year: 2003
Tongue: English
Weight: 124 KB
Volume: 18
Category: Article
ISSN: 0179-1958
DOI: 10.1007/s00384-002-0464-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of sunitinib as maintenan

Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer

✍ Gervais, Radj; Hainsworth, John D.; Blais, Normand; Besse, Benjamin; Laskin, Jan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 264 KB

A single-arm, multicenter, open-label ph

A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma

✍ Christian Wülfing; Jean-Pascal H. Machiels; Dirk J. Richel; Marc-Oliver Grimm; U 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

A phase II study of sabarubicin (MEN-107

A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer

✍ Francesco Caponigro; Pax Willemse; Roberto Sorio; Anne Floquet; Simon van Belle; 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 81 KB

Docetaxel plus epidoxorubicin as neoadju

Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast : A single-center, Phase II study

✍ Andrea de Matteis; Francesco Nuzzo; Giuseppe D'Aiuto; Vincenzo Labonia; Gabriell 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to test the activity and toxicity of epirubicin plus docetaxel as primary chemotherapy for women with large, operable (T2; > 3 cm) or locally advanced (Stage III) breast carcinoma, including patients with inflammatory breast carcinoma. ##

Phase II study of oral vinorelbine in co

Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma

✍ Reck, Martin; Macha, Hans-Nikol; Del Barco, Sonia; Cornes, Paul; Vaissière, Nath 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 280 KB

A Randomized Phase II Study of Pemetrexe

A Randomized Phase II Study of Pemetrexed in Combination With Cisplatin or Carboplatin as First-Line Therapy for Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

✍ Schuette, Wolfgang H.W.; Gröschel, Andreas; Sebastian, Martin; Andreas, Stefan; 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 534 KB